0001613103-23-000070.txt : 20230802
0001613103-23-000070.hdr.sgml : 20230802
20230802194351
ACCESSION NUMBER: 0001613103-23-000070
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230731
FILED AS OF DATE: 20230802
DATE AS OF CHANGE: 20230802
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PARKHILL KAREN L
CENTRAL INDEX KEY: 0001527660
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36820
FILM NUMBER: 231137616
MAIL ADDRESS:
STREET 1: 1717 MAIN STREET, MC 6402
CITY: DALLAS
STATE: TX
ZIP: 75201
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Medtronic plc
CENTRAL INDEX KEY: 0001613103
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 000000000
FISCAL YEAR END: 0427
BUSINESS ADDRESS:
STREET 1: 20 ON HATCH, LOWER HATCH STREET
CITY: DUBLIN
STATE: L2
ZIP: 2
BUSINESS PHONE: 01135314381700
MAIL ADDRESS:
STREET 1: 20 ON HATCH, LOWER HATCH STREET
CITY: DUBLIN
STATE: L2
ZIP: 2
FORMER COMPANY:
FORMER CONFORMED NAME: Medtronic Ltd
DATE OF NAME CHANGE: 20150112
FORMER COMPANY:
FORMER CONFORMED NAME: Medtronic Holdings Ltd
DATE OF NAME CHANGE: 20140711
FORMER COMPANY:
FORMER CONFORMED NAME: Kalani I Ltd
DATE OF NAME CHANGE: 20140709
4
1
wk-form4_1691019823.xml
FORM 4
X0508
4
2023-07-31
0
0001613103
Medtronic plc
MDT
0001527660
PARKHILL KAREN L
710 MEDTRONIC PARKWAY
MINNEAPOLIS
MN
55432
0
1
0
0
EVP & Chief Financial Officer
0
Ordinary Shares
2023-07-31
4
A
0
12535
0
A
44418
D
Ordinary Shares
49859
I
Jeffrey S. Parkhill 2021 Irrevocable Trust
Ordinary Shares
843
I
By Child #1
Ordinary Shares
843
I
By Child #2
Ordinary Shares
843
I
By Child #3
Performance Share Units
2023-07-31
4
A
0
31336
0
A
Performance Share Unit
31336
31336
D
Stock Option (Right to Buy)
87.76
2023-07-31
4
A
0
88254
0
A
2033-07-31
Ordinary Shares
88254
88254
D
Restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.
Includes 921 units acquired through dividend reinvestment since the last report filed by the reporting person.
These shares are held in the Jeffrey S. Parkhill 2021 Irrevocable Trust, of which the insider is the trustee and a beneficiary.
Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 31,336 shares will be issued. If maximum performance metrics are achieved, 62,672 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
Vests on July 31, 2026.
These options become exercisable at the rate of 25% of the shares granted beginning on the first anniversary of the grant.
/s/ Thomas L. Osteraas, attorney-in-fact
2023-08-02